Meet DES Pharma Consulting at 17th World ADC San Diego
Connect with DES experts to discuss ADC bioprocess scale-up, analytical & potency development, CDMO selection, tech transfer, and lifecycle CMC strategy for antibody-drug conjugates and complex biologics.
Dates
October 12–15, 2026
Location
San Diego, California
Event
17th World ADC San Diego
Meeting Request
Schedule time with DES at World ADC
DES can route requests to the most relevant principal based on modality, function, and program needs.
Prefer to book instantly? Schedule directly via Calendly
About the 17th World ADC San Diego Summit
The 17th World ADC San Diego Summit is the industry’s longest-standing, most definitive forum dedicated to antibody-drug conjugates. Bringing together over 1,300 industry leaders, scientists, clinicians, and manufacturing partners across discovery, translation, clinical development, CMC, and supply chain, World ADC is the premier orientation point for advancing next-generation bioconjugates and bringing targeted therapies to oncology patients.
For registration, agenda details, and venue information, visit worldadc-usa.com.
Meet with DES at World ADC
DES Pharma Consulting is a specialized biopharmaceutical consulting firm focused on accelerating the development, manufacturing, and commercialization of advanced biotherapeutics and conjugate modalities. Founded by industry veterans with hands-on experience across CMC, analytical development, and supply chain management, DES helps biopharma organizations de-risk development pathways, resolve critical manufacturing challenges, and execute successful regulatory milestones.
Bioprocess Design & Conjugation Scale-Up
Analytical Development & Potency Strategy
CDMO Selection & Commercial Tech Transfer
Process Characterization, DoE & PPQ Readiness
Quality Assurance & GMP Remediation
Supply Chain Architecture & Network Optimization
Who you’ll meet
Connect directly with DES leaders aligned to your program’s process, analytical, CMC, supply chain, software and AI priorities.
Meade Medaugh
Process, CMC & Scale-Up Strategy
Bioprocess design, scale-up, and IND-enabling CMC strategy across advanced biologics and conjugate modalities.
- Bioprocess development and scale-up
- CMC strategy and manufacturing readiness
- Technology transfer and cost-of-goods (COGs) optimization
Isaac G. Jeganathan
CDMO & Supply Chain Strategy
Global supply chain leadership spanning CDMO oversight, technology transfer, procurement, and network optimization.
- CDMO evaluation, contracting, and oversight
- Commercial product launch & global tech transfer
- Procurement, ERP execution, and supply network optimization
Andres Maraone
Principal Consultant, AI and Full-Stack Engineer
Pharma AaaS & SaaS
Scalable architectures, automating workflows, integrating third-party APIs, and delivering production-ready solutions
- Pharma enterprise software
- AI-powered applications, SaaS platforms, and mobile apps
- Large-scale systems integrations
Matthew Pontrelli
Principal Consultant, Process Development & CMC
Late-Stage CMC, QbD & PPQ Readiness
Specialized in Quality by Design (QbD), DoE statistical modeling, and process characterization for biologics development.
- Downstream purification & optimization
- Scale-down model qualification and parameter classification
- PPQ readiness, validation protocols, and tech transfer packages